The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

With Eli Lilly’s Mounjaro entering India, the weight-loss drug race is on. But with steep prices and generics on the way, how ...

Mounjaro (tirzepatide) is an FDA-approved antidiabetic injection gaining popularity for its effectiveness in weight ...

Amy Schumer endorses the new weight loss drug Mounjaro, praising its effectiveness after an adverse experience with Wegovy.

It was only a matter of time until the GLP-1 receptor agonist drugs like Ozempic and Wegovy were superseded, and now it looks ...

1,2 This article evaluates weight loss injections (such as semaglutide) by examining who may benefit, who should avoid them, and the potential health implications based on current scientific evidence.

As obesity rates continue to climb globally, the demand for effective weight loss medication has intensified, making these a focal point of modern treatment strategies. Such injections not only aid in ...

Women who have quickly lost weight say strangers are now more likely to smile at them or strike up a conversation.

As research continues, Mounjaro may redefine medical weight loss strategies, but its ethical implications and long-term ...

Eli Lilly launched its weight loss drug Mounjaro in India. According to the company, the injection is supposed to be taken ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to ...